Literature DB >> 9859693

[Treatment of mucosal leishmaniasis with aminosidine sulfate: results of two year follow-up].

G A Romero1, H A Lessa, M G Orge, V O Macêdo, P D Marsden.   

Abstract

In 1996, 20 of 21 patients with mucosal leishmaniasis, treated in 1994 with aminosidine sulfate, 16mg/kg/day salt, by intramuscular injection for 20 days, were clinically evaluated. One patient died due to disease not related to mucosal leishmaniasis. Seven of 14 patients (66.7% N = 21) who achieved complete remission three months after treatment remained clinically cured 24 months later and seven relapsed in the same period (50% N = 14). Sorological follow-up showed poor correlation with the results of clinical examination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9859693     DOI: 10.1590/s0037-86821998000600001

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

3.  Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans.

Authors:  Ana Claudia Maretti-Mira; Jaime Bittner; Manoel Paes Oliveira-Neto; Minghsun Liu; Dezhi Kang; Huiying Li; Claude Pirmez; Noah Craft
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.